Cargando…

Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine

PURPOSE OF REVIEW: P4 medicine denotes an evolving field of medicine encompassing predictive, preventive, personalized, and participatory medicine. Using the example of kidney allograft rejection because of donor-recipient incompatibility in human leukocyte antigens, this review outlines P4 medicine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maier, Mirela, Takano, Tomoko, Sapir-Pichhadze, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308536/ https://www.ncbi.nlm.nih.gov/pubmed/28270929 http://dx.doi.org/10.1177/2054358116688227

Ejemplares similares

Policy Challenges for Organ Allocation in an Era of “Precision Medicine”
por: Caulfield, Timothy, et al.
Publicado: (2020)

Editorial: Future challenges and directions in determining allo-immunity in kidney transplantation
por: Lim, Wai H., et al.
Publicado: (2022)

Sex and gender considerations in transplantation research: protocol for a scoping review
por: Laprise, Claudie, et al.
Publicado: (2017)

Kidney Transplantation in Times of Covid-19: Decision Analysis in the Canadian Context
por: Yanev, Ivan, et al.
Publicado: (2021)

Web-Based Self-Management Guide for Kidney Transplant Recipients (The Getting on With Your Life With a Transplanted Kidney Study): Protocol for Development and Preliminary Testing
por: Massierer, Daniela, et al.
Publicado: (2019)

Predicting Clinical Outcome in Expanded Criteria Donor Kidney Transplantation: A Retrospective Cohort Study
por: Saha-Chaudhuri, Paramita, et al.
Publicado: (2020)

Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online public deliberation
por: Slomp, Caitlin, et al.
Publicado: (2023)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Ashwagandha and Kidney Transplant Rejection
por: Sriperumbuduri, Sriram, et al.
Publicado: (2020)

Pathophysiology of Rejection in Kidney Transplantation
por: Tamargo, Christina L., et al.
Publicado: (2023)

Preventing Rejection of the Kidney Transplant
por: Malhotra, Divyanshu, et al.
Publicado: (2023)

Opportunities for Engaging Patients in Kidney Research
por: Demian, Maryam N., et al.
Publicado: (2017)

Updates in Kidney Transplantation From the 2022 Banff-Canadian Society of Transplantation Joint Meeting: Conference Report
por: Carrigan, Ian, et al.
Publicado: (2023)

On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss
por: Mohammadhassanzadeh, Hossein, et al.
Publicado: (2021)

Sex matters: COVID-19 in kidney transplantation
por: Vinson, Amanda J., et al.
Publicado: (2021)

Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19
por: Iovino, Claudio, et al.
Publicado: (2021)

Kidney Transplant Rejection: Diagnosis and Treatment
por: Nasri-Chenijani, Sina
Publicado: (1987)

Educational Case: Kidney Transplant Rejection
por: Kuan, Kevin, et al.
Publicado: (2021)

Current Therapies in Kidney Transplant Rejection
por: Alasfar, Sami, et al.
Publicado: (2023)

Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology
por: Hobeika, Christian, et al.
Publicado: (2023)

Kidney Rejection Following Simultaneous Liver-kidney Transplantation
por: Shah, Sapna, et al.
Publicado: (2020)

Tissue Engineering and Regenerative Medicine: Semantic Considerations for an Evolving Paradigm
por: Katari, Ravi, et al.
Publicado: (2015)

Alloimmune Risk Stratification for Kidney Transplant Rejection
por: Bestard, Oriol, et al.
Publicado: (2022)

Adding epitope compatibility to deceased donor kidney allocation criteria: recommendations from a pan-Canadian online public deliberation
por: Edwards, Louisa, et al.
Publicado: (2023)

A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring
por: Giarraputo, Alessia, et al.
Publicado: (2021)

Protocol Biopsy After Kidney Transplant: Clinical Application and Efficacy to Detect Allograft Rejection
por: Moein, Mahmoudreza, et al.
Publicado: (2023)

‘Cells as tools’ to ‘Cell-s produced tools’ - An evolving paradigm in Regenerative Medicine
Publicado: (2017)

An evolving paradigm for the secretory pathway?
por: Lippincott-Schwartz, Jennifer
Publicado: (2011)

The evolving treatment paradigm in myelofibrosis
por: Mesa, Ruben A.
Publicado: (2013)

Evolving Paradigms in Melanoma Therapy
por: Olszanski, Anthony J., et al.
Publicado: (2016)

Evolving paradigm in thrombophilia screening
por: Ashraf, Noman, et al.
Publicado: (2019)

Evolving treatment paradigms for PCV
por: Fenner, Beau J., et al.
Publicado: (2021)

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Aly, Ragia, et al.
Publicado: (2020)

Physician Practice Patterns and Barriers to Counselling on Physical Activity in Solid Organ Transplant Recipients
por: Pang, Amy, et al.
Publicado: (2018)

Clinical application of immune repertoire sequencing in solid organ transplant
por: Wong, Paaksum, et al.
Publicado: (2023)

Antibody-Mediated Rejection in Kidney Transplantation: A Review
por: Puttarajappa, Chethan, et al.
Publicado: (2012)

Tackling Chronic Kidney Transplant Rejection: Challenges and Promises
por: Lai, Xingqiang, et al.
Publicado: (2021)

The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection
por: Rogulska, Karolina, et al.
Publicado: (2022)

Perturbations of the T-cell immune repertoire in kidney transplant rejection
por: Sigdel, Tara K., et al.
Publicado: (2022)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
por: Abuazzam, Farah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nvi92b8c5kikneij7ah12shvn9